Oxantel disrupts polymicrobial biofilm development of periodontal pathogens

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 1, 2014, Pages 378-385

  Dashper, Stuart ^a   O'Brien Simpson, Neil ^a   Liu, Sze Wei ^a   Paolini, Rita ^a   Mitchell, Helen ^a   Walsh, Katrina ^a   D'Cruze, Tanya ^a   Hoffmann, Brigitte ^a   Catmull, Deanne ^a   Zhu, Ying ^a   Reynolds, Eric ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CELL EXTRACT; DRINKING WATER; FUMARATE REDUCTASE; HEME; OXANTEL EMBONATE; TRANSCRIPTOME;

ALVEOLAR BONE LOSS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIUM CULTURE; BIOFILM; CELL COUNT; CHRONIC PERIODONTITIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; GENE EXPRESSION; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; OPERON; POLYMICROBIAL BIOFILM; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULON; TANNERELLA FORSYTHENSIS; TREPONEMA DENTICOLA; UPREGULATION;

ANIMALS; ANTINEMATODAL AGENTS; BIOFILMS; MICE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PYRANTEL; SUCCINATE DEHYDROGENASE; TREPONEMA DENTICOLA;

EID: 84891509937     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01375-13     Document Type: Article

References (58)

1. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. 2012. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J. Dent. Res. 91:914-920. http://dx.doi.org/10.1177/0022034512457373.
2. Oliver RC, Brown LJ, Loe H. 1998. Periodontal diseases in the United States population. J. Periodontol. 69:269-278. http://dx.doi.org/10.1902/jop. 1998.69.2.269.
3. Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R. 1998. Periodontitis: a risk factor for coronary heart disease? Ann. Periodontol. 3:127- 141. http://dx.doi.org/10.1902/annals.1998.3.1.127.
4. Spahr A, Klein E, Khuseyinova N, Boeckh C, Muche R, Kunze M, Rothenbacher D, Pezeshki G, Hoffmeister A, Koenig W. 2006. Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch. Intern. Med. 166:554-559. http://dx.doi.org/10.1001/archinte.166.5.554.
5. Guha N, Boffetta P, Wunsch Filho V, Eluf Neto J, Shangina O, Zaridze D, Curado MP, Koifman S, Matos E, Menezes A, Szeszenia-Dabrowska N, Fernandez L, Mates D, Daudt AW, Lissowska J, Dikshit R, Brennan P. 2007. Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am. J. Epidemiol. 166:1159-1173. http://dx.doi.org/10.1093/aje/kwm193.
6. Tezal M, Sullivan MA, Reid ME, Marshall JR, Hyland A, Loree T, Lillis C, Hauck L, Wactawski-Wende J, Scannapieco FA. 2007. Chronic periodontitis and the risk of tongue cancer. Arch. Otolaryngol. Head Neck Surg. 133:450-454. http://dx.doi.org/10.1001/archotol.133.5.450.
7. Hujoel PP, Drangsholt M, Spiekerman C, Weiss NS. 2003. An exploration of the periodontitis-cancer association. Ann. Epidemiol. 13:312-316. http://dx.doi.org/10.1016/S1047-2797(02)00425-8.
8. Stolzenberg-Solomon RZ, Dodd KW, Blaser MJ, Virtamo J, Taylor PR, Albanes D. 2003. Tooth loss, pancreatic cancer, and Helicobacter pylori. Am. J. Clin. Nutr. 78:176-181. http://ajcn.nutrition.org/content/78/1/176.long.
9. Michaud DS, Joshipura K, Giovannucci E, Fuchs CS. 2007. A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J. Natl. Cancer Inst. 99:171-175. http://dx.doi.org/10.1093/jnci/ djk021.
10. Ioannidou E, Kao D, Chang N, Burleson J, Dongari-Bagtzoglou A. 2006. Elevated serum interleukin-6 (IL-6) in solid-organ transplant recipients is positively associated with tissue destruction and IL-6 gene expression in the periodontium. J. Periodontol. 77:1871-1878. http://dx.doi.org/10.1902/jop.2006. 060014.
11. Darveau RP. 2010. Periodontitis: a polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 8:481-490. http://dx.doi.org/10.1038/ nrmicro2337.
12. Hajishengallis G, Lamont RJ. 2012. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol. Oral Microbiol. 27:409-419. http://dx.doi.org/10.1111/j. 2041-1014.2012.00663.x.
13. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL, Jr. 1998. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25:134-144. http://dx.doi.org/10.1111/j.1600-051X.1998.tb02419.x.
14. Byrne SJ, Dashper SG, Darby IB, Adams GG, Hoffmann B, Reynolds EC. 2009. Progression of chronic periodontitis can be predicted by the levels of Porphyromonas gingivalis and Treponema denticola in subgingival plaque. Oral Microbiol. Immunol. 24:469-477. http://dx.doi.org/10.1111/j.1399-302X.2009. 00544.x.
15. Haffajee AD, Socransky SS, Smith C, Dibart S. 1991. Relation of baseline microbial parameters to future periodontal attachment loss. J. Clin. Periodontol. 18:744-750. http://dx.doi.org/10.1111/j.1600-051X.1991.tb00066.x.
16. Brown LF, Beck JD, Rozier RG. 1994. Incidence of attachment loss in community-dwelling older adults. J. Periodontol. 65:316-323. http://dx.doi.org/10.1902/jop.1994.65.4.316.
17. Kesavalu L, Holt SC, Ebersole JL. 1998. Virulence of a polymicrobic complex, Treponema denticola and Porphyromonas gingivalis, in a murine model. Oral Microbiol. Immunol. 13:373-377. http://dx.doi.org/10.1111/j.1399-302X.1998. tb00694.x.
18. Kesavalu L, Sathishkumar S, Bakthavatchalu V, Matthews C, Dawson D, Steffen M, Ebersole JL. 2007. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect. Immun. 75:1704-1712. http://dx.doi.org/10.1128/IAI.00733-06.
19. Orth RK, O'Brien-Simpson NM, Dashper SG, Reynolds EC. 2011. Synergistic virulence of Porphyromonas gingivalis and Treponema denticola in a murine periodontitis model. Mol. Oral Microbiol. 26:229-240. http://dx.doi.org/10.1111/ j.2041-1014.2011.00612.x.
20. Kuramitsu HK, Chen W, Ikegami A. 2005. Biofilm formation by the periodontopathic bacteria Treponema denticola and Porphyromonas gingivalis. J. Periodontol. 76:2047-2051. http://dx.doi.org/10.1902/jop.2005.76.11-S.2047.
21. Yamada M, Ikegami A, Kuramitsu HK. 2005. Synergistic biofilm formation by Treponema denticola and Porphyromonas gingivalis. FEMS Microbiol. Lett. 250:271-277. http://dx.doi.org/10.1016/j.femsle.2005.07.019.
22. Zainal-Abidin Z, Veith PD, Dashper SG, Zhu Y, Catmull DV, Chen YY, Heryanto DC, Chen D, Pyke JS, Tan K, Mitchell HL, Reynolds EC. 2012. Differential proteomic analysis of a polymicrobial biofilm. J. Proteome Res. 11:4449-4464. http://dx.doi.org/10.1021/pr300201c.
23. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49:711-745. http://dx.doi.org/ 10.1146/annurev.mi.49.100195.003431.
24. Cvitkovitch DG, Li YH, Ellen RP. 2003. Quorum sensing and biofilm formation in streptococcal infections. J. Clin. Invest. 112:1626-1632. http://dx.doi.org/10.1172/JCI20430.
25. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193. http://dx.doi.org/10.1128/CMR.15.2.167-193.2002.
26. Kroger A, Geisler V, Lemma E, Theis F, Lenger R. 1992. Bacterial fumarate respiration Arch. Microbiol. 158:311-314.
27. Choi WY, Lee OR, Lee WK, Kim WK, Chung CS, Ough BO. 1979. A clinical trial of oxantel and pyrantel against intestinal nematodes infections. Kisaengch'ung Hak Chapchi 17:60-66.
28. Garcia EG. 1976. Treatment for trichuriasis with oxantel. Am. J. Trop. Med. Hyg. 25:914-915.
29. Horton L. 2003. The efficacy of anthelmintics: past, present, and future, p 143-155. In Crompton D, Montresor A, Nesheim M, Savioli L (ed), Controlling disease due to helminth infections. World Health Organization, Geneva, Switzerland.
30. Bossche VD. 1985. Handbook of experimental pharmacology. Springer, New York, NY.
31. Fornelio C, Caabeiro R, Gonzalez J. 1987. The mode of action of some benzimidazole drugs on Trichinella spiralis. Parasitology 95:61-70. http://dx.doi.org/10.1017/S0031182000057541.
32. Harrow ID, Gration KA, Evans NA. 1991. Neurobiology of arthropod parasites. Parasitology 102(Suppl):S59 -S69.
33. Martin RJ, Murray I, Robertson AP, Bjorn H, Sangster N. 1998. Anthelmintics and ion-channels: after a puncture, use a patch. Int. J. Parasitol. 28:849-862. http://dx.doi.org/10.1016/S0020-7519(98)00048-4.
34. Prichard RK. 1970. Mode of action of the anthelminthic thiabendazole in Haemonchus contortus. Nature 228:684-685. http://dx.doi.org/10.1038/228684a0.
35. Dashper S, Ang CS, Liu SW, Paolini R, Veith P, Reynolds E. 2010. Inhibition of Porphyromonas gingivalis biofilm by oxantel. Antimicrob. Agents Chemother. 54:1311-1314. http://dx.doi.org/10.1128/AAC.00946-09.
36. Leschine SB, Canale-Parola E. 1980. Rifampin as a selective agent for isolation of oral spirochetes. J. Clin. Microbiol. 12:792-795.
37. Zhu Y, Dashper SG, Chen Y-Y, Crawford S, Slakeski N, Reynolds EC. 2013. Porphyromonas gingivalis and Treponema denticola synergistic polymicrobial biofilm development. PLoS One 8:e71727. http://dx.doi.org/10.1371/journal.pone. 0071727.
38. Dashper SG, Ang CS, Veith PD, Mitchell HL, Lo AW, Seers CA, Walsh KA, Slakeski N, Chen D, Lissel JP, Butler CA, O'Brien-Simpson NM, Barr IG, Reynolds EC. 2009. Response of Porphyromonas gingivalis to heme limitation in continuous culture. J. Bacteriol. 191:1044-1055. http://dx.doi.org/10.1128/JB.01270-08.
39. Dashper SG, O'Brien-Simpson NM, Cross KJ, Paolini RA, Hoffmann B, Catmull DV, Malkoski M, Reynolds EC. 2005. Divalent metal cations increase the activity of the antimicrobial peptide kappacin. Antimicrob. Agents Chemother. 49:2322-2328. http://dx.doi.org/10.1128/AAC.49.6.2322-2328.2005.
40. Sakamoto M, Takeuchi Y, Umeda M, Ishikawa I, Benno Y. 2001. Rapid detection and quantification of five periodontopathic bacteria by realtime PCR. Microbiol. Immunol. 45:39-44.
41. Fujise O, Hamachi T, Inoue K, Miura M, Maeda K. 2002. Microbiological markers for prediction and assessment of treatment outcome following non-surgical periodontal therapy. J. Periodontol. 73:1253-1259. http://dx.doi.org/10.1902/jop.2002.73.11.1253.
42. Lo AW, Seers CA, Boyce JD, Dashper SG, Slakeski N, Lissel JP, Reynolds EC. 2009. Comparative transcriptomic analysis of Porphyromonas gingivalis biofilm and planktonic cells.BMCMicrobiol. 9:18. http://dx.doi.org/10.1186/1471- 2180-9-18.
43. Pathirana RD, O'Brien-Simpson NM, Brammar GC, Slakeski N, Reynolds EC. 2007. Kgp and RgpB, but not RgpA, are important for Porphyromonas gingivalis virulence in the murine periodontitis model. Infect. Immun. 75:1436-1442. http://dx.doi.org/10.1128/IAI.01627-06.
44. Mendz GL, Hazell SL, Srinivasan S. 1995. Fumarate reductase: a target for therapeutic intervention against Helicobacter pylori. Arch. Biochem. Biophys. 321:153-159. http://dx.doi.org/10.1006/abbi.1995.1380.
45. Takahashi N, Sato T, Yamada T. 2000. Metabolic pathways for cytotoxic end product formation from glutamate- and aspartate-containing peptides by Porphyromonas gingivalis. J. Bacteriol. 182:4704-4710. http://dx.doi.org/10. 1128/JB.182.17.4704-4710.2000.
46. Mendz GL, Meek DJ, Hazell SL. 1998. Characterization of fumarate transport in Helicobacter pylori. J. Membr. Biol. 165:65-76. http://dx.doi.org/10.1007/s002329900421.
47. Smith MA, Mendz GL, Jorgensen MA, Hazell SL. 1999. Fumarate metabolism and the microaerophily of Campylobacter species. Int. J. Biochem. Cell Biol. 31:961-975. http://dx.doi.org/10.1016/S1357-2725(99)00062-X.
48. Mileni M, MacMillan F, Tziatzios C, Zwicker K, Haas AH, Mantele W, Simon J, Lancaster CR. 2006. Heterologous production in Wolinella succinogenes and characterization of the quinol:fumarate reductase enzymes from Helicobacter pylori and Campylobacter jejuni. Biochem. J. 395: 191-201. http://dx.doi.org/10. 1042/BJ20051675.
49. Roper JM, Raux E, Brindley AA, Schubert HL, Gharbia SE, Shah HN, Warren MJ. 2000. The enigma of cobalamin (vitamin B12) biosynthesis in Porphyromonas gingivalis. Identification and characterization of a functional corrin pathway. J. Biol. Chem. 275:40316-40323. http://dx.doi.org/10.1074/jbc.M007146200.
50. Schifferle RE, Shostad SA, Bayers-Thering MT, Dyer DW, Neiders ME. 1996. Effect of protoporphyrin 9 limitation on Porphyromonas gingivalis. J. Endod. 22:352-355. http://dx.doi.org/10.1016/S0099-2399(96)80216-0.
51. Dashper SG, Pan Y, Veith PD, Chen YY, Toh EC, Liu SW, Cross KJ, Reynolds EC. 2012. Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity. Antimicrob. Agents Chemother. 56:1548-1556. http://dx.doi.org/10.1128/AAC.05100-11.
52. Kigure T, Saito A, Seida K, Yamada S, Ishihara K, Okuda K. 1995. Distribution of Porphyromonas gingivalis and Treponema denticola in human subgingival plaque at different periodontal pocket depths examined by immunohistochemical methods. J. Periodontal Res. 30:332-341. http://dx.doi.org/10.1111/j.1600-0765.1995.tb01284.x.
53. Simonson LG, Robinson PJ, Pranger RJ, Cohen ME, Morton HE. 1992. Treponema denticola and Porphyromonas gingivalis as prognostic markers following periodontal treatment. J. Periodontol. 63:270-273. http://dx.doi.org/10.1902/ jop.1992.63.4.270.
54. Grenier D. 1992. Nutritional interactions between two suspected periodontopathogens, Treponema denticola and Porphyromonas gingivalis. Infect. Immun. 60:5298-5301.
55. Ito R, Ishihara K, Shoji M, Nakayama K, Okuda K. 2010. Hemagglutinin/adhesin domains of Porphyromonas gingivalis play key roles in coaggregation with Treponema denticola. FEMS Immunol. Med. Microbiol. 60:251-260. http://dx.doi.org/10.1111/j.1574-695X.2010.00737.x.
56. Kolenbrander PE. 2000. Oral microbial communities: biofilms, interactions, and genetic systems. Annu. Rev. Microbiol. 54:413-437. http://dx.doi.org/10.1146/annurev.micro.54.1.413.
57. Yao ES, Lamont RJ, Leu SP, Weinberg A. 1996. Interbacterial binding among strains of pathogenic and commensal oral bacterial species. Oral Microbiol. Immunol. 11:35-41. http://dx.doi.org/10.1111/j.1399-302X.1996.tb00334.x.
58. O'Brien-Simpson NM, Pathirana RD, Paolini RA, Chen YY, Veith PD, Tam V, Ally N, Pike RN, Reynolds EC. 2005. An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss. J. Immunol. 175:3980-3989. http://www.jimmunol.org/content/175/6/3980.long.